从牛初乳中分离提取乳铁蛋白,建立快速分离纯化乳铁蛋白的工艺.选择弱酸性阳离子交换剂CM-SEPHAROSE FAST FLOW装柱,脱脂牛初乳在4℃下进行动态吸附上柱后进行阶跃洗脱.通过对洗脱条件的比较优化,确定了分离提取乳铁蛋白的最佳工艺条件...从牛初乳中分离提取乳铁蛋白,建立快速分离纯化乳铁蛋白的工艺.选择弱酸性阳离子交换剂CM-SEPHAROSE FAST FLOW装柱,脱脂牛初乳在4℃下进行动态吸附上柱后进行阶跃洗脱.通过对洗脱条件的比较优化,确定了分离提取乳铁蛋白的最佳工艺条件为:牛初乳料液pH 6.6,上柱速度300 mL/h,阶跃洗脱剂的体积分数分别为1.5%和5.0%的NaCl,洗脱体积流速200 mL/h.乳铁蛋白洗脱液经过超滤和冷冻干燥,得到冻干粉纯度可达98.98%,得率为29.0%.展开更多
讨论了从牛初乳中分离乳铁蛋白的工艺。结果表明,牛初乳经过离心脱脂得到脱脂乳,加入带羧甲基的弱酸性阳离子交换剂CM-Sepharose Fast Flow在4℃下进行动态吸附,用去离子水将没有吸附上的杂蛋白冲洗掉,然后使用质量分数为1.5%和5%的NaC...讨论了从牛初乳中分离乳铁蛋白的工艺。结果表明,牛初乳经过离心脱脂得到脱脂乳,加入带羧甲基的弱酸性阳离子交换剂CM-Sepharose Fast Flow在4℃下进行动态吸附,用去离子水将没有吸附上的杂蛋白冲洗掉,然后使用质量分数为1.5%和5%的NaCl溶液进行阶跃洗脱;经过两步阶跃洗脱得到的乳铁蛋白纯度可达95%以上。展开更多
目的:建立快速、简便测定鲜牛奶、转基因牛奶和人乳中乳铁蛋白的方法。方法:在对样品脱脂和去除酪蛋白时,水洗乳脂、酪蛋白以提高乳铁蛋白的回收率。通过十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(sodiumdodecyl sulfate-polyacrylamide gel e...目的:建立快速、简便测定鲜牛奶、转基因牛奶和人乳中乳铁蛋白的方法。方法:在对样品脱脂和去除酪蛋白时,水洗乳脂、酪蛋白以提高乳铁蛋白的回收率。通过十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(sodiumdodecyl sulfate-polyacrylamide gel electrophoresis,SDS-PAGE)分离乳清蛋白,薄层扫描法定量。对电泳和薄层扫描的条件进行优化,电泳使用1.0mm×10齿的试样格、分离胶质量浓度12g/mL、分离电压100V、上样量5μL、染色3h、脱色2h;薄层扫描采取锯齿、双波长、透射的扫描方式,Y步长和摆幅宽分别为0.1mm和8mm。结果:可以分离不同来源乳中的乳铁蛋白、α-乳白蛋白和β-乳球蛋白;乳铁蛋白加标回收率分别为104.53%、108.37%,同板精密度RSD值为3.1003%和1.8151%,在100～2000μg/mL范围内呈线性关系,相关系数为0.9988和0.9990。结论:此方法可以用于3种乳中乳铁蛋白的测定。展开更多
Helicobacter pylori (H. pylori) eradication is considered a necessary step in the management of peptic ulcer disease, chronic gastritis, gastric adenocarcinoma and mucosa associated lymphoid tissue lymphoma. Standard ...Helicobacter pylori (H. pylori) eradication is considered a necessary step in the management of peptic ulcer disease, chronic gastritis, gastric adenocarcinoma and mucosa associated lymphoid tissue lymphoma. Standard triple therapy eradication regimens are inconvenient and achieve unpredictable and often poor results. Eradication rates are decreasing over time with increase in antibiotic resistance. Fermented milk and several of its component whey proteins have emerged as candidates for complementary therapy. In this context the current review seeks to summarize the current evidence available on their role in H. pylori eradication. Pertinent narrative/systematic reviews, clinical trials and laboratory studies on individual components including fermented milk, yogurt, whey proteins, lactoferrin, α-lactalbumin (α-LA), glycomacropeptide and immunoglobulin were comprehensively searched and retrieved from Medline, Embase, Scopus, Cochrane Controlled Trials Register and abstracts/proceedings of conferences up to May 2013. A preponderance of the evidence available on fermented milk-based probiotic preparations and bovine lactoferrin suggests a beneficial effect in Helicobacter eradication. Evidence for α-LA and immunoglobulins is promising while that for glycomacropeptide is preliminary and requires substantiation. The magnitude of the potential benefit documented so far is small and the precise clinical settings are ill defined. This restricts the potential use of this group as a complementary therapy in a nutraceutical setting hinging on better patient acceptability/compliance. Further work is necessary to identify the optimal substrate, fermentation process, dose and the ideal clinical setting (prevention/treatment, first line therapy/recurrence, symptomatic/asymptomatic, gastritis/ulcer diseases etc.). The potential of this group in high antibiotic resistance or treatment failure settings presents interesting possibilities and deserves further exploration.展开更多
文摘讨论了从牛初乳中分离乳铁蛋白的工艺。结果表明,牛初乳经过离心脱脂得到脱脂乳,加入带羧甲基的弱酸性阳离子交换剂CM-Sepharose Fast Flow在4℃下进行动态吸附,用去离子水将没有吸附上的杂蛋白冲洗掉,然后使用质量分数为1.5%和5%的NaCl溶液进行阶跃洗脱;经过两步阶跃洗脱得到的乳铁蛋白纯度可达95%以上。
文摘目的:建立快速、简便测定鲜牛奶、转基因牛奶和人乳中乳铁蛋白的方法。方法:在对样品脱脂和去除酪蛋白时,水洗乳脂、酪蛋白以提高乳铁蛋白的回收率。通过十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(sodiumdodecyl sulfate-polyacrylamide gel electrophoresis,SDS-PAGE)分离乳清蛋白,薄层扫描法定量。对电泳和薄层扫描的条件进行优化,电泳使用1.0mm×10齿的试样格、分离胶质量浓度12g/mL、分离电压100V、上样量5μL、染色3h、脱色2h;薄层扫描采取锯齿、双波长、透射的扫描方式,Y步长和摆幅宽分别为0.1mm和8mm。结果:可以分离不同来源乳中的乳铁蛋白、α-乳白蛋白和β-乳球蛋白;乳铁蛋白加标回收率分别为104.53%、108.37%,同板精密度RSD值为3.1003%和1.8151%,在100～2000μg/mL范围内呈线性关系,相关系数为0.9988和0.9990。结论:此方法可以用于3种乳中乳铁蛋白的测定。
基金Supported by Intramural funding by Sitaram Bhartia Institute of Science and Research,New Delhi
文摘Helicobacter pylori (H. pylori) eradication is considered a necessary step in the management of peptic ulcer disease, chronic gastritis, gastric adenocarcinoma and mucosa associated lymphoid tissue lymphoma. Standard triple therapy eradication regimens are inconvenient and achieve unpredictable and often poor results. Eradication rates are decreasing over time with increase in antibiotic resistance. Fermented milk and several of its component whey proteins have emerged as candidates for complementary therapy. In this context the current review seeks to summarize the current evidence available on their role in H. pylori eradication. Pertinent narrative/systematic reviews, clinical trials and laboratory studies on individual components including fermented milk, yogurt, whey proteins, lactoferrin, α-lactalbumin (α-LA), glycomacropeptide and immunoglobulin were comprehensively searched and retrieved from Medline, Embase, Scopus, Cochrane Controlled Trials Register and abstracts/proceedings of conferences up to May 2013. A preponderance of the evidence available on fermented milk-based probiotic preparations and bovine lactoferrin suggests a beneficial effect in Helicobacter eradication. Evidence for α-LA and immunoglobulins is promising while that for glycomacropeptide is preliminary and requires substantiation. The magnitude of the potential benefit documented so far is small and the precise clinical settings are ill defined. This restricts the potential use of this group as a complementary therapy in a nutraceutical setting hinging on better patient acceptability/compliance. Further work is necessary to identify the optimal substrate, fermentation process, dose and the ideal clinical setting (prevention/treatment, first line therapy/recurrence, symptomatic/asymptomatic, gastritis/ulcer diseases etc.). The potential of this group in high antibiotic resistance or treatment failure settings presents interesting possibilities and deserves further exploration.
